Seizures in HIV-seropositive individuals: Epidemiology and treatment

CNS Drugs

Volumn 16, Issue 2, 2002, Pages 91-98

  Romanelli, Frank ^a   Ryan, Melody ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; CARBAMAZEPINE; CLONAZEPAM; DELAVIRDINE; DIAZEPAM; EFAVIRENZ; GABAPENTIN; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PHENOBARBITAL; PHENYTOIN; RITONAVIR; SAQUINAVIR; STAVUDINE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZIDOVUDINE;

BINDING AFFINITY; DISEASE COURSE; DROWSINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGAMMAGLOBULINEMIA; MEDICAL DECISION MAKING; NAUSEA AND VOMITING; NEURALGIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEIZURE; TREATMENT PLANNING; VERTIGO; VIRUS LOAD; VIRUS REPLICATION;

EID: 0036174819     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200216020-00002     Document Type: Review

References (41)

1. Neurologic manifestations of HIV infection
2. Temporal trends in the incidence of HIV-1 related neurologic disease: Multicenter AIDS cohort study
3. Neurological manifestations of acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature
4. Neurological complications of acquired immunodeficiency syndrome: Analysis of patients
5. New-onset seizures associated with human immunodeficiency virus infection: Causation and clinical features in 100 cases
6. Seizures in human immunodeficiency virus infection
7. Therapeutic dilemma: The use of anticonvulsants in HIV-positive individuals
8. Prospective analysis of seizures occurring in human immunodeficiency virus type-I infection
9. New-onset generalized seizures in patients with AIDS presenting to an emergency department
10. Prospective study of new onset seizures in patients with human immunodeficiency virus infection
11. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
12. Should people be treated after a first seizure?
13. Should people be treated after a first seizure?
14. USPHS/IDSA 1999 guidelines for the prevention and treatment of opportunistic infections in persons infected with human immunodeficiency virus
15. Severe phenytoin intoxication as a result of altered protein binding in AIDS
16. Therapeutic drug monitoring of phenytoin in patients with the acquired immunodeficiency syndrome
17. Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus
18. Significant interactions with new antiretrovirals and psychotropic drugs
19. Hyper IgE and human immunodeficiency virus infection
20. Serum IgE in patients with human immunodeficiency virus infection
21. Adverse reactions to trimethoprim-sulfamethoxazole in patients with acquired immunodeficiency syndrome
22. Evaluation of gastrointestinal absorption and metabolism
23. The role of blood brain barrier in HIV infection of the central nervous system
24. Protease inhibitors in patients with HIV disease: Clinically important pharmacokinetic consideration
25. Public health implications of antiretroviral therapy and HIV drug resistance
26. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection
27. Carbamazepine-indinavir interaction causes antiretroviral therapy failure
28. Protease inhibitor-induced carbamazepine toxicity
29. Potential interaction between ritonavir and carbamazepine
30. Ritonavir-induced carbamazepine toxicity
31. Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women
32. Adverse effects of antiepileptic drugs on bone structure: Epidemiology, mechanisms, and therapeutic implications
33. Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels
34. Cell type dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitro
35. Intracellular glutathione levels in T cell subsets decrease in HIV infected individuals
36. Sodium valproate, an anticonvulsant, stimulates human cytomegalovirus replication
37. The use of valproic acid in HIV-positive patients
38. Tiagabine: A novel antiepileptic drug
39. Enzyme induction and inhibition by new antiepileptic drugs: A review of human trials